FBIO (Fortress Biotech) Interest Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FBIO Fortress Biotech Inc FBIO
46 GF Score
Price $3.63
GF Value $1.25
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Fortress Biotech Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

FBIO
46GF Score
Fortress Biotech Inc FBIO
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Fortress Biotech (FBIO) Overvalued in 2026?

Based on GuruFocus' analysis, Fortress Biotech stock appears to be overvalued. The current stock price of $3.63 is trading 190.4% above its estimated GF Value™ of $1.25. GuruFocus considers Fortress Biotech to be Significantly Overvalued.

Key valuation signals for FBIO:

  • Interest Received:
  • GF Value™: $1.25 vs. price of $3.63 (190.4% above fair value)
  • GF Score™: 46/100 with 7 warning signs

No single metric tells the full story. See the FBIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fortress Biotech Business Description

Address 1111 Kane Concourse, Suite 301, Bay Harbor Island, FL, USA, 33154
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.
46GF Score

Get the complete analysis for FBIO

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.63
Price
$1.25
GF Value